Intervention Strategies to Reduce the Most Common Barriers to Care Among Adolescent and Young Adult Oncology Patients

November 2018 Vol 9, NO 11
Christina Miller, MS, LCPC
The Ulman Cancer Fund for Young Adults
Meghan van der Eijk, MSW, LICSW
The Ulman Cancer Fund for Young Adults
Samantha Horn, MA
The Ulman Cancer Fund for Young Adults
Megan Solinger, MHS, MA, OPM-CG
The Ulman Cancer Fund for Young Adults
Alexandra Gubin, MSW, LCSW-C
The Ulman Cancer Fund for Young Adults
Nicole Sanchez Herrera, BA
The Ulman Cancer Fund for Young Adults
Francesca Music
The Ulman Cancer Fund for Young Adults

Background: Approximately 72,000 adolescents and young adults (AYA), defined by the National Comprehensive Cancer Network1 as ages 15-39 years, are diagnosed with cancer each year. A cancer diagnosis during this life stage generates unique medical and psychosocial needs as developmental milestones are simultaneously impacted.2 Social isolation and alienation are commonly reported among AYA patients and survivors.3 Even after treatment ends, survivors continue to express concerns about finances and job discrimination.4 The Ulman Cancer Fund for Young Adults (UCF) addresses these issues by employing AYA patient navigators.

Objectives: The purpose of this multisite study was to: (1) Identify common barriers for AYA patients across treatment sites, and (2) Demonstrate intervention strategies used to reduce these barriers. To measure and improve the quality of AYA oncology patient navigation, programs must use standardized metrics and focus on evidence-based practice.

Methods: The study took place January 1, 2017, through June 30, 2018. A total of 561 unique patients were included in the data collection, which tracked patients from 5 large cancer centers in the Baltimore/DC region. A Google Form was used to gather data, with each AYA patient navigator entering information for each patient they supported on a monthly basis. This study tracked the variation in barriers and the intervention strategies used to address them.

Results: Among the 561 unique patients tracked, the most common diagnoses were breast cancer (14%), acute lymphocytic leukemia (12%), Hodgkin lymphoma (10%), and brain cancers (8%). The median age was 28 years, with a racial distribution of 56% white, 27% black, 8% Hispanic, 7% Asian, and 2% mixed/other. Sex was nearly equally distributed. In order of highest count, the most commonly cited issues that AYAs faced were social isolation, limited support, side effects and late effects, general financial need, adjusting to illness and/or hospitalization, dealing with work or school, mental health, understanding diagnosis and treatment, communication with medical team, and fertility. The most commonly cited interventions, in order of highest count, were one-on-one emotional support, encouragement, UCF program referrals, routine check-ins, logistical support, referral to social or educational activities, resources related to coping with diagnosis, treatment and side effects, referral to other staff or hospital resource, facilitation of communication/coordination among medical team, and fertility preservation education.

Conclusion: In addition to their unique medical needs, AYAs have informational and psychosocial needs that most programs do not address.2 They include information about diagnosis, age-specific support groups, and fertility preservation, as well as financial, practical, and peer support. Optimal quality care was described as including awareness among providers of the unique psychosocial context for AYA growth and development and referral to age-appropriate resources during treatment. This is precisely what the UCF AYA Patient Navigation model aims to do. The current study highlights the age-specific resources and referrals AYA patient navigators rely on to help patients overcome the most common barriers they face (social isolation, financial need, fertility, etc).


References

  1. National Comprehensive Cancer Network. NCCN Guidelines for Patients. Adolescent and Young Adults with Cancer. Version 1, 2017. But I’m too young to have cancer! www.nccn.org/patients/guidelines/aya/files/assets/basic-html/page-10.html.
  2. Institute of Medicine. Identifying and addressing the needs of adolescents and young adults with cancer. Workshop summary. www.nap.edu/read/18547/chapter/2#introx-ch1. 2013.
  3. Zebrack B, Hamilton R, Wilder Smith A. Psychosocial outcomes and service use among young adults with cancer. Semin Oncol. 2009;36:468-477.
  4. Roberts CS, Severinsen C, Carraway C, et al. Life changes and problems experienced by young adults with cancer. Journal of Psychosocial Oncology. 1997;15(1):15-25.
Related Articles
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
November 2022 Vol 13, No 11
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country